申请人:Combs Andrew P.
公开号:US20100015178A1
公开(公告)日:2010-01-21
The present invention is directed to 1,2,5-oxadiazole derivatives, and compositions of the same, which are inhibitors of indoleamine 2,3-dioxygenase and are useful in the treatment of cancer and other disorders, and to the processes and intermediates for making such 1,2,5-oxadiazole derivatives.
本发明涉及1,2,5-噁二唑衍生物及其组合物,它们是色胺酸2,3-双氧酶的抑制剂,可用于治疗癌症和其他疾病,并涉及制备此类1,2,5-噁二唑衍生物的过程和中间体。